David Bloom treats and ensures follow-up for patients who suffer from schizophrenia and bipolar disorder.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

Patricia Boksa conducts research on pregnancy and birth complications as risk factors for the later development of schizophrenia.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Martin Lepage uses using functional magnetic resonance imaging (fMRI) to study memory deficits in patients with schizophrenia.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

Lalit Srivastava, has conducted research on schizophrenia and dopamine, a brain chemical implicated in its development.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Mathieu Brodeur, PhD, is studying how the brain uses information to find, recognize, and recall objects in a particular setting.

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...